FDA Warns of Ketoacidosis Risk with Newer Diabetes Drugs Typically used in Type 2 Diabetes they decrease glucose absorption and increase urinary glucose excretion. FDA Warns of Ketoacidosis Risk with Newer Diabetes Drugs. Share this:TwitterFacebookPocketRedditPinterestEmailTumblrLinkedInLike this:Like Loading... Related